SANOFI (1SAN.MI) Stock Overview
Europe - BIT:1SAN - FR0000120578 - Common Stock
1SAN.MI Key Statistics, Chart & Performance
The current stock price of 1SAN.MI is 89.09 EUR. In the past month the price increased by 12.15%. In the past year, price increased by 3.16%.
1SAN.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1LLY.MI | ELI LILLY & CO | 51.52 | 678.33B | ||
| LLY.DE | ELI LILLY & CO | 51.52 | 678.23B | ||
| ZEG.DE | ASTRAZENECA PLC | 18.87 | 444.61B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 18.48 | 397.91B | ||
| JNJ.DE | JOHNSON & JOHNSON | 18.32 | 394.53B | ||
| RHO.DE | ROCHE HOLDING AG-BR | 14.45 | 248.76B | ||
| 1ROG.MI | ROCHE HOLDING AG-GENUSSCHEIN | 13.92 | 239.54B | ||
| 1NOVN.MI | NOVARTIS AG-REG | 15.01 | 218.75B | ||
| NOT.DE | NOVARTIS AG-REG | 14.96 | 218.05B | ||
| SNW.DE | SANOFI | 14.45 | 216.58B | ||
| SAN.PA | SANOFI | 14.44 | 216.39B | ||
| NOV.DE | NOVO NORDISK A/S-B | 13.75 | 204.09B |
Related stock screener links
About 1SAN.MI
Company Profile
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 84,587 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Company Info
SANOFI
46 Avenue de la Grande Armee
Paris ILE-DE-FRANCE FR
Employees: 84587
Phone: 33153774000
SANOFI / 1SAN.MI FAQ
Can you describe the business of SANOFI?
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 84,587 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
What is the current price of 1SAN stock?
The current stock price of 1SAN.MI is 89.09 EUR. The price increased by 3.03% in the last trading session.
What is the dividend status of SANOFI?
SANOFI (1SAN.MI) has a dividend yield of 4.53%. The yearly dividend amount is currently 3.79.
What is the ChartMill technical and fundamental rating of 1SAN stock?
1SAN.MI has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Which stock exchange lists 1SAN stock?
1SAN.MI stock is listed on the Euronext Milan exchange.
Would investing in SANOFI be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1SAN.MI.
What is the employee count for 1SAN stock?
SANOFI (1SAN.MI) currently has 84587 employees.
1SAN.MI Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to 1SAN.MI. When comparing the yearly performance of all stocks, 1SAN.MI turns out to be only a medium performer in the overall market: it outperformed 44.73% of all stocks.
1SAN.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1SAN.MI. 1SAN.MI scores excellent on profitability, but there are some minor concerns on its financial health.
1SAN.MI Financial Highlights
Over the last trailing twelve months 1SAN.MI reported a non-GAAP Earnings per Share(EPS) of 6.15. The EPS decreased by -23.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.35% | ||
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| Debt/Equity | 0.21 |
1SAN.MI Forecast & Estimates
29 analysts have analysed 1SAN.MI and the average price target is 109.22 EUR. This implies a price increase of 22.59% is expected in the next year compared to the current price of 89.09.
For the next year, analysts expect an EPS growth of 4.12% and a revenue growth -0.42% for 1SAN.MI